Paul B Fisher Selected Research

Interleukins

12/2021	Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.
1/2019	MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
1/2018	Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.
1/2016	mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.
11/2015	Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
11/2015	MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
2/2015	Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach.
1/2015	Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.
8/2014	Characterization of the canine mda-7 gene, transcripts and expression patterns.
1/2014	Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul B Fisher Research Topics

Disease

226	Neoplasms (Cancer) 03/2022 - 07/2002
126	Melanoma (Melanoma, Malignant) 01/2022 - 01/2002
42	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2004
35	Infections 11/2021 - 01/2002
29	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2003
26	Glioma (Gliomas) 01/2018 - 02/2003
23	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2005
21	Carcinoma (Carcinomatosis) 01/2019 - 03/2002
20	Hepatocellular Carcinoma (Hepatoma) 09/2019 - 09/2008
19	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 07/2003
16	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 01/2005
15	Carcinogenesis 01/2020 - 01/2005
9	Inflammation (Inflammations) 01/2022 - 10/2004
8	Ovarian Neoplasms (Ovarian Cancer) 07/2012 - 08/2004
7	Leukemia 03/2020 - 03/2010
6	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 11/2007
6	Virus Diseases (Viral Diseases) 01/2016 - 02/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2003
5	Neuroblastoma 11/2021 - 06/2009
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2013 - 07/2003
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2013 - 12/2003
5	Kidney Neoplasms (Kidney Cancer) 01/2013 - 05/2009
5	Lung Neoplasms (Lung Cancer) 06/2012 - 05/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2011 - 02/2007
4	Brain Neoplasms (Brain Tumor) 10/2017 - 02/2003
4	Exanthema (Rash) 01/2007 - 05/2002
3	Hypoxia (Hypoxemia) 01/2021 - 12/2009

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
62	InterleukinsIBA 12/2021 - 08/2003
57	CytokinesIBA 01/2022 - 02/2003
30	SynteninsIBA 01/2021 - 11/2004
23	Pharmaceutical PreparationsIBA 11/2019 - 10/2006
14	Messenger RNA (mRNA)IBA 02/2015 - 01/2002
13	Interleukin-10 (Interleukin 10)IBA 12/2021 - 05/2004
13	Phosphotransferases (Kinase)IBA 07/2011 - 03/2004
11	Small Interfering RNA (siRNA)IBA 12/2015 - 05/2007
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2003
10	mezereinIBA 11/2020 - 01/2002
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 12/2003
9	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2005
9	Biological ProductsIBA 12/2021 - 10/2002
9	ErbB Receptors (EGF Receptor)IBA 01/2020 - 08/2004
9	AD 5IBA 01/2018 - 06/2010
9	CeramidesIBA 09/2011 - 05/2009
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2012
8	SyndecansIBA 01/2021 - 11/2004
8	NF-kappa B (NF-kB)IBA 01/2017 - 10/2004
8	CaspasesIBA 01/2016 - 02/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 02/2011
7	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2017
7	AntigensIBA 01/2021 - 01/2007
7	Histone Deacetylase InhibitorsIBA 01/2016 - 12/2007
7	Glutamic Acid (Glutamate)FDA Link 01/2015 - 02/2003
7	Interferon Type IIBA 03/2014 - 10/2003
7	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 09/2008
7	Polyribonucleotide Nucleotidyltransferase (Polynucleotide Phosphorylase)IBA 01/2013 - 07/2003
6	EnzymesIBA 01/2022 - 12/2002
6	InterferonsIBA 12/2021 - 01/2002
6	Interferon-betaIBA 11/2020 - 01/2002
6	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2010
6	Caspase 3 (Caspase-3)IBA 01/2017 - 04/2008
6	LigandsIBA 01/2017 - 03/2004
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2015 - 07/2006
6	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015 - 05/2010
6	p38 Mitogen-Activated Protein KinasesIBA 01/2014 - 07/2002
6	adenovirus receptorIBA 01/2011 - 07/2003
5	Antiviral Agents (Antivirals)IBA 01/2020 - 07/2006
5	Micrococcal NucleaseIBA 09/2019 - 04/2012
5	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2016 - 01/2002
5	AgarIBA 03/2015 - 08/2004
5	VaccinesIBA 01/2014 - 05/2008
5	RNA Helicases (RNA Helicase)IBA 03/2008 - 01/2002
4	CateninsIBA 02/2021 - 12/2013
4	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2004
4	Tamoxifen FDA LinkGeneric 01/2018 - 01/2013
4	Hormones (Hormone)IBA 03/2016 - 11/2003
4	Peptide Hydrolases (Proteases)FDA Link 03/2014 - 04/2007
4	Drug CombinationsIBA 03/2014 - 10/2006
4	Caspase 9IBA 10/2013 - 04/2008
4	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 02/2007
4	tanespimycin (17AAG)IBA 03/2011 - 01/2008
4	Endoplasmic Reticulum Chaperone BiPIBA 12/2010 - 08/2006
4	Vorinostat FDA Link 08/2010 - 12/2007
3	interleukin-24 (ST16)IBA 01/2022 - 01/2002
3	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 02/2010
3	Cadherins (E-Cadherin)IBA 02/2021 - 11/2016
3	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2004
3	Beclin-1IBA 01/2018 - 05/2010
3	GoldIBA 01/2018 - 12/2015
3	CarcinogensIBA 01/2017 - 06/2015
3	Insulin-Like Growth Factor Binding ProteinsIBA 01/2017 - 04/2013
3	vandetanib (ZD6474)IBA 01/2017 - 04/2010
3	Tyrosine Kinase InhibitorsIBA 01/2017 - 04/2010
3	EphA2 ReceptorIBA 03/2016 - 07/2014

Therapy/Procedure

124	Therapeutics 01/2022 - 01/2002
25	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
11	Immunotherapy 01/2021 - 10/2005
10	Radiotherapy 10/2017 - 07/2003
4	Injections 12/2021 - 09/2006